Share This

Public company info - Ocumension Therapeutics , 01477.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Ocumension Therapeutics, 01477.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12
Net Cash Flow from Operating Activities -200,243 -196,849 -212,574 -108,088 -43,350
Net Cash Flow from Return on Investments & Servicing of Finance 25,436 22,524 2,068 -63 20
　Interest Received 27,229 23,091 2,127 0 25
　Interest Paid -1,793 -567 -59 -63 -5
　Dividend Received 0 0 0 0 0
　Dividend Paid 0 0 0 0 0
　Others 0 0 0 0 0
Taxes (Paid) / Refunded -414 0 0 0 0
Net Cash Flow from Investing Activities 201,917 -1,368,381 627,569 -979,917 -66,685
　Additions to Fixed Assets -115,812 -195,370 -50,167 -766 -278
　Disposal of Fixed Assets 0 0 0 0 0
　Increase in Investments -179,990 -2,013,409 -1,343,702 -1,482,214 -102,874
　Decrease in Investments 181,243 1,955,622 1,832,083 1,061,608 36,707
　Net Cash Flow with Related Parties 0 0 0 -70,749 68,285
　Others 316,476 -1,115,224 189,355 -487,796 -68,525
Net Cash Flow before Financing Activities 26,696 -1,542,706 417,063 -1,088,068 -110,015
Net Cash Flow from Financing Activities -7,429 669,419 1,527,419 1,241,688 136,986
　New Loans 0 0 0 0 0
　Loans Repayment -9,147 -3,815 -1,382 -939 -46
　Fixed Income/Debt Instruments 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0
　Equity Financing 12,720 674,622 1,528,801 21 24
　Net Cash Flow with Related Parties 0 0 0 -70,749 68,285
　Others -11,002 -1,388 0 1,313,355 68,723
Increase(Decrease) in Cash & Cash Equivalents 19,267 -873,287 1,944,482 153,620 26,971
Cash & Cash Equivalents at Beginning of Year 1,125,221 2,034,319 192,404 25,629 0
Net Cash Flow due to Change in Exchange Rate/Others 25,561 -35,811 -102,567 13,155 -1,342
Cash & Cash Equivalents at End of Year 1,170,049 1,125,221 2,034,319 192,404 25,629
Currency Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.